Skip Navigation

  1. About Us
    1. Overview
    2. History
    3. Recognition
    4. Offices
  2. Our Practice
    1. Practice Areas
      1. Patents, Utility Models, and Industrial Designs
      2. Trademarks
      3. Copyrights
      4. Corporate, Commercial and Business Law
      5. IP Litigation, Alternative Dispute Resolution
      6. Regulatory Law
      7. Licensing, Tech Transfer & Franchising
      8. Anti-Piracy, Anti-Counterfeiting & Enforcement
    2. Industry Groups
      1. Media, Sports & Entertainment Law Group
      2. Life Science & Pharmaceutical Law Group
  3. Our People
    1. Partners
      1. Sergio L. Olivares, Sr. † (1931-2010)
      2. Sergio L. Olivares, Jr.
      3. Luis C. Schmidt
      4. Cesar Ramos, Jr.
      5. Antonio Belaunzaran
      6. Gustavo A. Alcocer
      7. Jose Ignacio De Santiago
      8. Alejandro Luna
      9. Alonso Camargo
      10. Daniel Sanchez
    2. Associates (A - M)
      1. Osvaldo Amaral
      2. Armando Arenas
      3. Sofía Arroyo
      4. Guillermo Ballesteros
      5. Varinia Calleros
      6. Abraham Diaz
      7. Georgina Flores
      8. Pedro Herrera
      9. Carlos Maya
    3. Associates (N - Z)
      1. Mauricio Narváez
      2. Víctor Ramírez
      3. Sergio Rangel
      4. Maria del Carmen Sada
      5. Juan Luis Serrano
      6. Guillermo Treviño
      7. Carlos Woodworth
    4. All Attorneys / Engineers
    5. Firm Administration
  4. Knowledge & Resources
    1. Articles
      1. Trademark Law Articles
        1. Use requirements
        2. Approach to composite marks changed, again
        3. Life Sciences Handbook 2011 - Country Q&A
        4. Mexico should accept secondary meaning
        5. Getting the Deal Through - Trademarks 2011
        6. Pharmaceutical Trademarks 2010/2011 - A Global Guide
        7. No legal basis for banning names derived from INNs
        8. How Latin America tackles cutting-edge IP issues
        9. Specialised IP court corrects IMPI
        10. Protecting trade dress
        11. 43 more items...
      2. Patent Law Articles
        1. Getting the Deal Through - Patents 2012
        2. Surge of Patent Application Final Rejections Provides Unique Opportunity for Patent Precent Making
        3. Mexico issues regulations to approve biologic drugs
        4. Latin America Roundtable
        5. New regulations pending
        6. The International Comparative Guide
        7. Marketing authorization for pharmaceutical
        8. Approval of follow-on biologics in Mexico
        9. Mexican Linkage Gazette April 2011
        10. Patent Prosecution Highway in Mexico
        11. 37 more items...
      3. Copyright Law Articles
        1. Advertising in social media networks
        2. Technology challenges digital rights
        3. Exceptions to copyright protection and the permitted uses of copyright works in the hi-tech and digital sectors
        4. Derechos sobre producción audiovisual
        5. How Latin America tackles cutting-edge IP issues
        6. Copyright Litigation 2010
        7. Legislation and enforcement - Copyrights 2010
        8. Valuing folklore
        9. Protecting novel ideas
        10. Mexico's fair use balancing act
        11. 100 more items...
      4. Corporate Law Articles
        1. Mexico issues Personal Data Protection Rules
        2. How data affects innovation
        3. A practical cross-border
        4. New registry for security interests
        5. The International Comparative Legal Guide to: Merger Control 2011
        6. The International Comparative Legal Guide to: Merger Control 2010
        7. Due diligence issues to consider in M&A
        8. Income expectations in licensing
        9. The reasons for valuation
        10. Amendments proposed to franchise regulation
      5. IP Litigation, ADR Articles
        1. Scope of new specialised courts widened
        2. Reform of preliminary injunctions
        3. Mexican Patent Office excludes Formulation Patents from Linkage Gazette
        4. Mexico gets ready to approve biocomparable drugs
        5. Mexico's hotel for the stars highlights power in the name
        6. Supreme Court upholds the worth of formulation patents
        7. Getting the Deal Through - Patents 2010
        8. Getting the Deal Through Trademarks 2010
        9. Trademark enforcement
        10. Venues for appealing IMPI decisions
        11. 15 more items...
      6. Regulatory Law Articles
        1. Recent amendment to the Federal Law for Consumer Protection
        2. Amendments to the Federal Law for Consumer Protection
        3. Mexico issues Personal Data Protection Rules
        4. New Regulations Pending
        5. Marketing authorization for pharmaceutical products to foreign applicants
        6. Data Package Exclusivity (DPE)
        7. Supreme Court upholds the worth of formulation patents
        8. Pharmaceutical trademarks
        9. Framework for biotherapeutic products established
        10. Pharmaceutical Advertising 2009
        11. 4 more items...
      7. Licensing, Tech Transfer Articles
        1. Creating a secure franchise system
      8. Anti-Piracy, Anti-Counterfeiting Articles
        1. New register against counterfeits
        2. Beat the counterfeiters in Mexico
        3. Battling counterfeits through Customs
        4. Getting the Deal Through Trademarks 2010
        5. Enforcing plant variety rights in Mexico
        6. Pharmaceutical Trademarks 2009
        7. Internet Issues
        8. Anti-counterfeiting 2009
        9. Vegetal variety rights enforced
        10. New Customs rules lead to seizures
        11. 3 more items...
      9. Media, Sports & Entertainment Focused Articles
        1. Advertising in social media networks
        2. Whither Rental Rights?
        3. Improved protection for personalities
      10. Life Sciences Focused Articles
        1. Latin America Roundtable
        2. New regulations pending
        3. The International Comparative
        4. Approval of follow-on biologics in Mexico
        5. Global Pharmaceutical Linkage Regulations:
        6. Life Sciences Handbook 2011 - Country Q&A
        7. Supreme Court upholds the worth of formulation patents
        8. Repercussions expected on medicine advertising campaign in Mexico
        9. Framework for biotherapeutic products established
        10. Pharmaceutical Trademarks 2009
        11. 1 more item...
    2. Webinar Archive
      1. Webinar - Changes to Mexican Patent and Healthcare Laws for Life Sciences
      2. Webinar - Digital Rights Issues in Copyright Law
      3. Webinar - Data Package Exclusivity Rights in Latin America
    3. Recognition
    4. News
      1. Mexico subscribes Madrid Protocol
      2. Presumed Guilty - How can a law firm help win an Emmy?
      3. New rules came in force to speed timeframes in administrative appeal proceedings
      4. Recent reforms to the Mexican Industrial Property Law dealing with trademark priority rights
      5. Olivares & Cia. ranking
      6. Data Package Exclusivity (DPE)
      7. Mr. Sergio Olivares Sr's Passing
      8. Pharma Linkage Regulations Supreme Court Decision
      9. Managing IP magazine has recognized Olivares & Cia. as the leading firm for patent work in Mexico
      10. Mexican Congress amends the Patent Law
      11. 1 more item...
  5. Events
  6. Offices
  7. Contact Us
  8. Quick guide to Mexico’s regulatory system
    1. Patent regulatory overview
    2. Trademark regulatory overview
    3. Copyright regulatory overview
    4. Corporate & Commercial Regulatory overview

Home » Knowledge & Resources » Articles » Copyright Law Articles » Liability for Contributory Infringement of IPRs

Liability for Contributory Infringement of IPRs

By Luis C. Schmidt
Partner
Question Q204, 2008

I. Analysis of current legislation and case law.

1) Does your national law provide for liability for contributory infringement of IPRs, in respect of the offering or supply of means for working an invention, for enabling illicit commercial use of a trademark, for making a copyrighted or design protected product, etc.

No

2) If so, is it a condition for such liability that the mans supplied are actually used by another (the person supplied) for committing acts amount to direct infringement of the IPR in the same country (or in another country where there is a corresponding IPR)? Are there any additional conditions that apply in such cases?

NA

3) If it is not a condition for liability for contributory infringement that the means supplied are actually used by another (the person supplied) for committing acts that amount to direct infringement in the same country (or in another country where there is a corresponding IPR), is it then, or the other hand, a condition for such liability, for example:

-that the means offered and/or supplied were suitable to be put into an infringing use;
-that the means relate to an essential, valuable or central element in the invention or product or service that constitutes direct infringement;
-that the means offered and/or supplied were actually intended for such use on the part of the person supplied;
-that the means offered and/or supply of the means, the suitability and intended use were known to the supplier or were obvious under the circumstances; or
-that, to the extent the means are staple commercial products, the supplier induces the person supplied to infringe directly?

4) Are there other conditions? Please respond separately for patents, trademarks, designs, copyright, etc., if the rules differ from each area of IPR to the other.

NA

5) Are the rules concerning contributory infringement set out in the laws protecting IPR?

NA

6) If such protection is not set out in the laws protecting IPR, does it follow from generally applicable principles of e.g. tort law?

NA

7) What are the legal consequences of holding an act to be a contributory infringement of and IPR, in particular:

-can the IPR owner obtain injunctive relief to the same extent as in case of direct infringement?
-can be IPR owner obtain damages and other compensation to the same extent as in case of direct infringement, or only relative to the contributory infringer’s contribution?
NA

II. Proposals for substantive harmonization

The Groups are invited to put forward their proposals for adoption of uniform rules, and in particular consider the following questions:

8) Should measures generally be available against acts that qualify as contributory infringement of IPR’s, as defined in these Working Guidelines?

Yes, at least in connection with patent and copyright law. Contributory infringement rules referenced to trademarks law are unclear. Concerning Copyright Law, contributory infringement is particularly urgent.

9) If so, what should be the conditions for holdings an act to be a contributory infringement of and IPR?

It should be no condition imposed at all. Contributory infringement should be opened not only when a contributory infringer offers or supplies means to perpetrable infringement, but also when induces or assists the direct infringes to violate the law.

10) Should the conditions be different for different kinds of IPRs? Why?

No. Rules just need to be broad enough to cover all array of possibilities.

11) What should be the legal consequences of holdings an act to amount to contributory infringement of an IPR, in particular?

-Should the IPR owner be able to obtain injunctive relief to the same extent as in case of direct infringement?
Yes
-Should the IPR owner be able to obtain damages and other compensation to the same extent as in case of direct infringement, or only relative to the contr ibutory infringer’s condition?
Yes

12) Should the legal consequences be different for different kinds of IPR? Why?

No

13) Does your Group have any other views or proposals for harmonization in this area?
SUMMARY
Mexican patent, trademark and copyright laws do not provide contributory infringement rules, applicable in connection with the offering or supply of means for working inventions, enabling the use of trademarks or making works of authorship or even inducing or assisting direct infringers to violate the laws. The Mexican group would support that pertinent IP laws are amended so that measures and remedies become available against all possible acts that qualify as contributory infringement, including the inducement and assistance for breaking the law.

The scope of contributory infringement rules should be as broad as possible. They should not only encompass patents, but should be extended to any other rights, like copyrights, that might be violated when third parties carry indirect acts of infringement. In Copyright Law, contributory infringement should not be restricted to when third parties offer or supply tangible means to the direct infringement to inflict a copyright infringement. Intermediary indirect infringement has a special connotation and an importance, in particular when the third parties induce or assist the direct infringes to violate the law. WIPO treaty standards should be enhanced. Likewise, intermediary liability should be balanced with a fair system of safe harbors protecting Internet intermediaries.